Flavonoids identified from Korean Citrus aurantium L. inhibit Non-Small Cell Lung Cancer growth in vivo and in vitro

[1]  Chi-Tang Ho,et al.  Chemistry and bioactivity of nobiletin and its metabolites , 2014 .

[2]  Yun‐Hi Kim,et al.  Determination of polyphenol components of Korean Scutellaria baicalensis Georgi using liquid chromatography–tandem mass spectrometry: Contribution to overall antioxidant activity , 2013 .

[3]  B. Patil,et al.  Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[4]  K. Park,et al.  Polyphenolic extract isolated from Korean Lonicera japonica Thunb. induce G2/M cell cycle arrest and apoptosis in HepG2 cells: involvements of PI3K/Akt and MAPKs. , 2012, Food and Chemical Toxicology.

[5]  A. A. Abd El-Aty,et al.  Flavonoid profiling in three citrus varieties native to the Republic of Korea using liquid chromatography coupled with tandem mass spectrometry: contribution to overall antioxidant activity. , 2012, Biomedical chromatography : BMC.

[6]  K. Park,et al.  Flavonoids Isolated from Korea Citrus aurantium L. Induce G2/M Phase Arrest and Apoptosis in Human Gastric Cancer AGS Cells , 2011, Evidence-based complementary and alternative medicine : eCAM.

[7]  B. Patil,et al.  Citrus limonin and its glucoside inhibit colon adenocarcinoma cell proliferation through apoptosis. , 2011, Journal of agricultural and food chemistry.

[8]  Z. Peng,et al.  Flavonoids health benefits and their molecular mechanism. , 2011, Mini reviews in medicinal chemistry.

[9]  K. Park,et al.  Korean Scutellaria baicalensis water extract inhibits cell cycle G1/S transition by suppressing cyclin D1 expression and matrix-metalloproteinase-2 activity in human lung cancer cells. , 2011, Journal of ethnopharmacology.

[10]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[11]  P. Mukherjee,et al.  Ethnopharmacology and integrative medicine – Let the history tell the future , 2010, Journal of Ayurveda and integrative medicine.

[12]  Guoqiang Chen,et al.  Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells. , 2010, Carcinogenesis.

[13]  F. Tsai,et al.  Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells. , 2009, Lung cancer.

[14]  J. Massagué,et al.  Molecular basis of metastasis. , 2008, The New England journal of medicine.

[15]  R. Jope,et al.  Identification of an antiapoptotic protein complex at death receptors , 2008, Cell Death and Differentiation.

[16]  F. Vesuna,et al.  Oncogenic role of DDX3 in breast cancer biogenesis , 2008, Oncogene.

[17]  G. Luo,et al.  Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo , 2008, Cancer biology & therapy.

[18]  S. Yim,et al.  Suppressive effects of nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression by Citrus reticulata extract in RAW 264.7 macrophage cells. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[20]  M. Hahne,et al.  APRIL promotes B-1 cell-associated neoplasm. , 2004, Cancer cell.

[21]  A. Fugh-Berman,et al.  Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss: Current Status of Clinical and Basic Research , 2004, Experimental biology and medicine.

[22]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[23]  C. Chen,et al.  Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. , 2004, Biochemical and biophysical research communications.

[24]  L. Maltais,et al.  The human DDX and DHX gene families of putative RNA helicases. , 2003, Genomics.

[25]  K. Vousden.  Activation of the p53 tumor suppressor protein. , 2002, Biochimica et biophysica acta.

[26]  K. Grohmann,et al.  Biological properties of citrus flavonoids pertaining to cancer and inflammation. , 2001, Current medicinal chemistry.

[27]  K. Kumagai,et al.  Experimental study of lymphogenous peritoneal cancer dissemination: migration of fluorescent-labelled tumor cells in a rat model of mesenteric lymph vessel obstruction. , 2000, Journal of experimental & clinical cancer research : CR.

[28]  A. Hsueh,et al.  Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm. , 2000, Physiological reviews.

[29]  C C Sigman,et al.  Cancer chemoprevention: progress and promise. , 1999, European journal of cancer.

[30]  J. Tschopp,et al.  APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth , 1998, The Journal of experimental medicine.

[31]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[32]  J. Aarbakke,et al.  A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA. , 1995, Cytometry.

[33]  John Calvin Reed,et al.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.

[34]  P. K. Horan,et al.  Stable cell membrane labelling , 1989, Nature.